These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 19072343)

  • 21. Molecular markers and genetics in cancer development.
    Hormi-Carver K; Souza RF
    Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barrett's esophagus: diagnostic challenges and recent developments.
    Maru DM
    Ann Diagn Pathol; 2009 Jun; 13(3):212-21. PubMed ID: 19433303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation and Barrett's carcinogenesis.
    Poehlmann A; Kuester D; Malfertheiner P; Guenther T; Roessner A
    Pathol Res Pract; 2012 May; 208(5):269-80. PubMed ID: 22541897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and recognition of early esophageal neoplasia.
    Herszényi L; Pregun I; Tulassay Z
    Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma--a case report.
    Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Miwa A
    Hepatogastroenterology; 2001; 48(42):1662-4. PubMed ID: 11813596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE).
    Cronin J; McAdam E; Danikas A; Tselepis C; Griffiths P; Baxter J; Thomas L; Manson J; Jenkins G
    Am J Gastroenterol; 2011 Jan; 106(1):46-56. PubMed ID: 21157443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 and the malignant progression of Barrett's esophagus.
    Merola E; Claudio PP; Giordano A
    J Cell Physiol; 2006 Mar; 206(3):574-7. PubMed ID: 16110481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biology of Barrett's cancer.
    Atherfold PA; Jankowski JA
    Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of the risk of adenocarcinoma in Barrett's esophagus by means of tumor markers (p53 and Ki67).
    Trakál E; Guidi A; Butti AL; Trakál JJ; Sambuelli R; Zárate FE
    Acta Gastroenterol Latinoam; 2010 Sep; 40(3):211-5. PubMed ID: 21049770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma.
    Breton J; Gage MC; Hay AW; Keen JN; Wild CP; Donnellan C; Findlay JB; Hardie LJ
    J Proteome Res; 2008 May; 7(5):1953-62. PubMed ID: 18396902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
    Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ
    J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus.
    Sarbia M; Arjumand J; Wolter M; Reifenberger G; Heep H; Gabbert HE
    Am J Clin Pathol; 2001 Jun; 115(6):835-40. PubMed ID: 11392879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.
    Hermann B; Li Y; Ray MB; Wo JM; Martin RC
    Arch Surg; 2005 Dec; 140(12):1204-9; discussion 1209. PubMed ID: 16365243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
    Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
    Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.